Fructosamine-3-kinase (FN3K) is an enzyme that plays a critical role in the metabolic processing of proteins that have undergone glycation, a form of non-enzymatic modification. Glycation occurs when sugar molecules spontaneously bond to proteins, which can disrupt their normal function and contribute to the degradation of cellular health over time. FN3K helps to reverse this modification by removing the attached sugar molecules, thus restoring the normal function of the affected proteins. Understanding the modulation of FN3K expression is of scientific interest because of its relevance to the maintenance of protein integrity and function within biological systems. The regulation of FN3K activity, whether by genetic or chemical means, can be a significant factor in maintaining proteostasis, particularly in the context of cellular aging and the associated accumulation of glycated proteins.
A range of chemical compounds have been identified as potential inhibitors of FN3K expression, acting through various biochemical pathways to downregulate or decrease the production of this enzyme at the transcriptional level. These compounds include flavonoids such as quercetin, myricetin, and kaempferol, which may inhibit FN3K expression by hindering specific signaling pathways that influence gene transcription. Similarly, polyphenols like resveratrol and curcumin are thought to reduce the expression of FN3K by altering the activity of transcription factors or enzymes that are involved in the regulation of gene expression. Other compounds such as sulforaphane and ellagic acid might also play a role in decreasing FN3K levels by activating or inhibiting cellular pathways that affect the transcription or stability of FN3K mRNA. These interactions between chemical compounds and the cellular machinery responsible for FN3K expression are complex and necessitate extensive research to unravel the precise mechanisms involved. It is through such detailed molecular investigation that our understanding of FN3K regulation and its biological significance continues to evolve.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $108.00 $245.00 $918.00 $49.00 | 33 | |
Quercetin could downregulate FN3K expression by inhibiting the JNK signaling pathway, which may control the transcription of the FN3K gene. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol may reduce FN3K expression by altering the activity of sirtuins, which are known to play a role in the transcriptional silencing of genes. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin has the potential to decrease FN3K expression by suppressing the activity of NF-κB, a transcription factor that may govern FN3K gene transcription. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Epigallocatechin Gallate could inhibit the expression of FN3K by providing an antioxidant effect that alters redox-sensitive transcription factors controlling FN3K expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Genistein might decrease FN3K transcription by interacting with estrogen receptors, leading to changes in the estrogen receptor-mediated transcription. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
DL-Sulforaphane may reduce FN3K expression by activating the Nrf2 pathway, which might change the transcription profile of detoxifying enzymes, including FN3K. | ||||||
Kaempferol | 520-18-3 | sc-202679 sc-202679A sc-202679B | 25 mg 100 mg 1 g | $97.00 $212.00 $500.00 | 11 | |
Kaempferol could downregulate FN3K by hindering the PI3K/Akt signaling pathways, which have a role in the translation of FN3K mRNA. | ||||||
Apigenin | 520-36-5 | sc-3529 sc-3529A sc-3529B sc-3529C sc-3529D sc-3529E sc-3529F | 5 mg 100 mg 1 g 5 g 25 g 100 g 1 kg | $32.00 $210.00 $720.00 $1128.00 $2302.00 $3066.00 $5106.00 | 22 | |
Apigenin has the potential to decrease FN3K transcription by altering kinase-mediated signaling pathways, leading to a reduction in FN3K gene transcription. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $26.00 $50.00 $99.00 $150.00 $1887.00 | 40 | |
Luteolin might reduce FN3K expression through its anti-inflammatory properties, leading to a decrease in cytokine-mediated FN3K gene transcription. | ||||||
Myricetin | 529-44-2 | sc-203147 sc-203147A sc-203147B sc-203147C sc-203147D | 25 mg 100 mg 1 g 25 g 100 g | $95.00 $184.00 $255.00 $500.00 $1002.00 | 3 | |
Myricetin could downregulate FN3K by disrupting signaling pathways associated with cellular stress and inflammatory responses that govern FN3K expression. | ||||||